In Vitro testing of Bilastine For Transporter Mediated Drug-Drug Interactions

被引：0
|
作者：
Ganza, Alvaro [1 ]
Ortega, Ignacio [1 ]
Gonzalo, Ana [1 ]
Luisa Lucero, Maria [1 ]
Jahic, Mirza [2 ]
Bednarczyk, Dallas [2 ]
Gedey, Szilvia
Nagy, Zoltan [4 ]
Juhasz, Viktoria [4 ]
Ioja, Eniko [3 ]
机构：
[1] Faes Farma, RDi, Vizcaya, Spain
[2] Optivia Biotechnol Inc, Menlo Pk, CA USA
[3] SOLVO Biotechnol, Res & Dev, Szeged, Hungary
[4] SOLVO Biotechnol, R&D, Budaors, Hungary
来源：
DRUG METABOLISM REVIEWS | 2010年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：303 / 303
页数：1
相关论文
共 50 条
  • [21] Transporter-enzyme interactions:: Implications for predicting drug-drug interactions from in vitro data
    Benet, LZ
    Cummins, CL
    Wu, CY
    CURRENT DRUG METABOLISM, 2003, 4 (05) : 393 - 398
  • [22] A pharmaceutical industry perspective on transporter and CYP-mediated drug-drug interactions: kidney transporter biomarkers
    Shen, Hong
    BIOANALYSIS, 2018, 10 (09) : 625 - 631
  • [23] The Impact and In Vitro to In Vivo Prediction of Transporter-Based Drug-Drug Interactions in Humans
    Unadkat, Jashvant D.
    Kirby, Brian J.
    Endres, Christopher J.
    Zolnerciks, Joseph K.
    ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, 2010, : 517 - 553
  • [24] Analysis of the mechanism of drug-drug interactions involving transporter-mediated hepatic uptake
    Shitara, Y
    Hirano, M
    Sato, H
    Sugiyama, Y
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2004, 124 : 37 - 41
  • [25] TRANSLATIONAL MODELING AND SAFETY ASSESSMENT OF TRANSPORTER-MEDIATED PHARMACOKINETICS AND DRUG-DRUG INTERACTIONS
    Galetin, Aleksandra
    DRUG METABOLISM REVIEWS, 2014, 45 : 16 - 17
  • [26] In Vitro Evaluation of Hepatic Transporter-Mediated Clinical Drug-Drug Interactions: Hepatocyte Model Optimization and Retrospective Investigation
    Bi, Yi-an
    Kimoto, Emi
    Sevidal, Samantha
    Jones, Hannah M.
    Barton, Hugh A.
    Kempshall, Sarah
    Whalen, Kevin M.
    Zhang, Hui
    Ji, Chengjie
    Fenner, Katherine S.
    El-Kattan, Ayman F.
    Lai, Yurong
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (06) : 1085 - 1092
  • [27] IN VITRO-IN VIVO CORRELATION FOR TRANSPORTER MEDIATED DRUG-DRUG INTERACTIONS WITH ROSUVASTATIN USING STATIC AND PBPK MODELS.
    Sane, R.
    Cheung, K.
    Kovacs, P.
    Farasyn, T.
    Plise, E.
    Bui, A.
    Musib, L.
    Kis, E.
    Li, R.
    Gaborik, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S84 - S84
  • [28] Drug-Drug Interactions at Organic Cation Transporter 1
    Zhou, Shiwei
    Zeng, Sujuan
    Shu, Yan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [29] Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions
    Muenster, Uwe
    Grieshop, Birgit
    Ickenroth, Karsten
    Gnoth, Mark Jean
    PHARMACEUTICAL RESEARCH, 2008, 25 (10) : 2320 - 2326
  • [30] Predicting drug-drug interactions:: In vitro veritas?
    Tucker, GT
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 23 : S13 - S13
12345